Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2

Indian J Med Res. 2020;152(1 & 2):124-126. doi: 10.4103/ijmr.IJMR_2609_20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections* / drug therapy
  • Health Personnel
  • Humans
  • Hydroxychloroquine
  • India
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Hydroxychloroquine